First GLP-1 analog liraglutide: the result of clinical trails on efficacy
This review analytically considers the results of clinical trials on efficacy and safety and clinical perspectives of GLP-1 analog liraglutide
Guardado en:
Autores principales: | Alexander Sergeevich Ametov, Lyudmila Leonidovna Kamynina |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fadfb6f4534043718b50e3d267ba37a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011) -
The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
por: Marina Vladimirovna Shestakova
Publicado: (2010) -
Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2017) -
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Campbell RK, et al.
Publicado: (2010) -
Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
por: Vladimir Ivanovich Kudinov, et al.
Publicado: (2011)